NTHIMEDIUM SIGNALRISK10-Q

NTHI shows deteriorating operating performance with substantially higher R&D spending and worsening cash burn despite minimal revenue generation.

The company's operating cash flow deteriorated by nearly 24% while R&D expenses grew substantially, indicating increased investment in development programs without corresponding revenue growth. With only $1.5M in cash and accumulated losses approaching $100M, the company faces mounting liquidity pressures that could impact its ability to fund operations.

Comparing 2025-11-14 vs 2025-08-18View on EDGAR →
FINANCIAL ANALYSIS

NTHI's financial position shows mixed signals, with current assets growing modestly to $2.1M while total liabilities declined to $16.6M, improving the overall balance sheet structure. However, operating performance deteriorated significantly as R&D expenses expanded substantially and operating cash flow worsened to -$7.0M. The minimal revenue base of $40K against mounting losses and cash burn suggests ongoing funding challenges for this development-stage company.

FINANCIAL STATEMENT CHANGES
Revenue
P&L
+100%
$20K$40K

Strong top-line growth of 100% — accelerating demand or successful expansion into new markets.

R&D Expense
P&L
+79.9%
$715K$1.3M

R&D investment increased 79.9% — signals commitment to future product development, though near-term margin impact.

Current Assets
Balance Sheet
+50.9%
$1.4M$2.1M

Current assets grew 50.9% — improving short-term liquidity or inventory/receivables build.

Stockholders Equity
Balance Sheet
+24.4%
-$17.5M-$13.2M

Equity base grew 24.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Operating Cash Flow
Cash Flow
-23.7%
-$5.7M-$7.0M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

Current Liabilities
Balance Sheet
-18.7%
$20.0M$16.3M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
-18.5%
$20.3M$16.6M

Liabilities reduced 18.5% — deleveraging improves balance sheet strength and financial flexibility.

Total Assets
Balance Sheet
+17.9%
$2.8M$3.3M

Asset base grew 17.9% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2025-11-14
PRIOR — 2025-08-18
ADDED
5 Note 1 Description of Business and Liquidity NeOnc Technologies, Inc.
At September 30, 2025, the Company had cash totaling $ 1,513,224 .
For the three and nine months ended September 30, 2025, the Company incurred a net loss of $ 8,615,920 and $ 46,622,106 , respectively, and has an accumulated deficit of $ 97,230,551 at September 30, 2025.
6 Note 2 Basis of Presentation and Summary of Significant Accounting Policies Basis of presentation The unaudited condensed consolidated financial statements contained herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the SEC ).
At September 30, 2025 and December 31, 2024, the Company has money market funds in the amount of approximately $ 12,000 and $ 25,000 , respectively.
+7 more — sign up free →
REMOVED
4 Note 1 Description of Business and Liquidity NeOnc Technologies, Inc.
For the three and six months ended June 30, 2025, the Company incurred a net loss of $ 5,680,170 and $ 38,006,186 , respectively, and has an accumulated deficit of $ 88,614,631 at June 30, 2025.
5 Note 2 Restatement of Previously Issued Financial Statements The Company has restated the previously issued unaudited consolidated financial statements as of and for the quarter ended March 31, 2025 (the Restatement ).
The Restatement corrects an error for an overstatement of amortization of stock based compensation during the three months ended March 31, 2025.
As previously reported in the Company s Current Report on Form 8-K filed on August 18, 2025, the management of the Company, after discussions with and among the Audit Committee of the Board of Directors concluded that the Company s unaudited consolidated financial statements as of and for quarter ended March 31, 2025 should no longer be relied upon and should be restated.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →